H. Mikkola et al., 4 NOVEL MUTATIONS IN DEFICIENCY OF COAGULATION-FACTOR-XIII - CONSEQUENCES TO EXPRESSION AND STRUCTURE OF THE A-SUBUNIT, Blood, 87(1), 1996, pp. 141-151
The characterization of naturally occurring mutations is one way to ap
proach functionally significant domains of polypeptides. About 10 muta
tions have been reported in factor XIII (FXIII) A-subunit deficiency,
but very little is known about the effects of the mutations on the exp
ression or the structure of this enzyme. In this study, the recent cry
stallization of FXIII A-subunit and determination of the three-dimensi
onal model were used for the first time to pursue the structural conse
quences of mutations in the A-subunit. The molecular analysis of four
families from Sweden, Germany, and Denmark revealed four previously un
reported point mutations. Three of the mutations were missense mutatio
ns, Arg326 --> Gln, Arg252 --> lie, and Leu498 --> Pro, and one was a
nonsense mutation, a deletion of thymidine in codon for Phe8 resulting
in early frameshift and premature termination of the polypeptide chai
n. In the case of the nonsense mutation, deIT Phe8, the steady-state m
RNA level of FXIII A-subunit was reduced, as quantitated by reverse tr
anscriptase-polymerase chain reaction and solid-phase minisequencing.
In contrast, none of the missense mutations affected mRNA levels, indi
cating the possible translation of the mutant polypeptides. However, b
y enzyme-linked immunosorbent analysis and immunofluorescence, all the
patients demonstrated a complete lack of detectable factor XIIIA anti
gen in their platelets. In the structural analysis, we included the mu
tations described in this work and the Met242 --> Thr mutation reporte
d earlier by us. Interestingly, in the three-dimensional model, all fo
ur missense mutations are localized in the evolutionarily conserved ca
talytic core domain. The substitutions are at least 15 A away from the
catalytic cleft and do not affect any of the residues known to be dir
ectly involved in the enzymatic reaction. The structural analyses sugg
est that the mutations are most likely interfering with proper folding
and stability of the protein, which is in agreement with the observed
absence of detectable FXIIIA antigen. Arg326, Arg252, and Met242 are
all buried within the molecule. The Arg326 --> Gln and Arg252 --> IIe
mutations are substitutions of smaller, neutral amino acids for large,
charged residues. They disrupt the electrostatic balance and hydrogen
-bonding interactions in structurally significant areas. The Met242 --
> Thr mutation is located in the same region of the core domain as the
Arg252 --> IIe site and is expected to have a destabilizing effect du
e to an introduction of a smaller, polar residue in a tightly packed h
ydrophobic pocket. The substitution of proline for Leu498 is predicted
to cause unfavorable interatomic contacts and a disruption of the alp
ha-helix mainchain hydrogen-bonding pattern; it is likely to form a ki
nk in the helix next to the dimer interface and is expected to impair
proper dimerization of the A-subunits. In the case of all four missens
e mutations studied, the knowledge achieved from the three-dimensional
model of crystallized FXIII A-subunit provides essential information
about the structural significance of the specific residues and aids in
understanding the biologic consequences of the mutations observed at
the cellular level. (C) 1996 by The American Society of Hematology.